Developer docs
API playgroundTry for free, no card

Search company profiles

LYVA Labs

Full company profile

uuid0005c1r

Namestring
LYVA Labs
Legal namestring
LCR Ventures Ltd
Websiteurl
lyvalabs.com
Company typeenum
Private
Founded yearint
2021
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLiverpool, United Kingdom
HQ citystring
Liverpool
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pre-seed investment, startup incubator programs, innovation accelerator services, R&D grant funding, venture capital support
Industry5 codes
PRIMARYBPAGAKAI
Research & Science Grantmaking Foundations
Business & Public Services/Nonprofit, NGO & Social Services/Philanthropy, Foundations & Grantmaking
SECONDARYBPAGAKAL
Health & Medical Research Grantmaking Foundations
Business & Public Services/Nonprofit, NGO & Social Services/Philanthropy, Foundations & Grantmaking
SECONDARYEDAEALAO
Research Administration & Grants Management Support (Pre/Post-Award, Compliance)
Education/Education Facilities & Support Services/Outsourced Operations & Managed Services for Education (BPO/Contracted Support)
SECONDARYFSANAJAI
Healthcare Access & Life Sciences Impact Funds
Financial & Insurance/Private Equity & Venture Capital/Impact / ESG & Sustainable Investment Funds
SECONDARYHLAJALAM
Workforce Development & Training Grants (Public Health)
Healthcare & Life Sciences/Public Health, Government & Regulators/Public Health Funding, Grants & Program Administration
NAICS code2 codes
  • Grantmaking Foundations813211
  • Voluntary Health Organizations813212
SIC code1 code
  • Investment Advice6282
Product category
Startup Investment & Innovation Support
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Grant-Funded Operations
TypeProfessional Services
Description

LYVA Labs operates as a publicly-funded innovation catalyst supported by the Liverpool City Region Combined Authority and UKRI/Innovate UK. The organization deploys investment capital and grant facilitation services at no cost to early-stage companies, generating social and economic returns for the region rather than commercial revenue.

Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
Pricing details1 tier
1Free support programs for qualifying early-stage companies
ModelOtherBilling cadenceMulti-year contract
Notes

Services are fully subsidized through public funding; no cost to participating startups or SMEs

GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 6 records shown
1Incubator Programme
Description

Early-stage support for founders developing innovative ideas into viable, investable businesses

lyvalabs.com
+5 more records
Core offering1 text field

LYVA Labs is Liverpool City Region's innovation investment company, providing pre-seed investment capital alongside structured Incubator (six-month) and Accelerate (nine-month) programmes, the Future Medicines Accelerator for advanced therapeutics and radiopharmaceuticals SMEs, R&D Partner Grant Funding matching up to £15,000 pound-for-pound, Consortia Building services for large-scale collaborations, and the Clean Tech for Health Fund offering up to £100,000. Its core focus sectors are health and life sciences, deep tech, and clean tech, and all services are delivered free of charge to qualifying early-stage startups and SMEs through public funding.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 35 early-stage companies invested in
+3 more records
Product overview1 text field

LYVA Labs is Liverpool City Region's innovation investment company that operates as a platform of interconnected support services rather than a single software product. The core offering comprises an Incubator Programme (6-month early-stage support with £25k investment), Accelerate Programme (9-month scale-up support), and Future Medicines Accelerator (Innovate UK-funded sector-specific programme). These are complemented by the Investment Fund (pre-seed capital for health, deep tech, and clean tech startups), R&D Partner Grant Funding (pound-for-pound matching grants up to £15k), Consortia Building services, and the Clean Tech for Health Fund (up to £100k pre-seed for sustainability-health innovations). The Entrepreneur Club provides ongoing alumni support. All programmes are delivered in partnership with regional institutions including Liverpool City Region Combined Authority, UKRI, Innovate UK, universities, and industry partners.

Product and service8 records
1Incubator Programme
CategoryStartup accelerator/incubator
Description

Six-month early-stage startup support programme offering £25,000 investment or consultancy budget, personalised account management, expert-led workshops, bespoke mentoring, grant application assistance, and concluding Demo Day investor pitches. For early-stage founders developing innovative ideas into viable, investable businesses in health/life sciences, deep tech, or clean tech.

2Accelerate Programme
CategoryStartup accelerator/incubator
Description

Nine-month intensive programme providing tailored expert support, guidance, and strategic insight for startups and SMEs ready to scale, secure investment and grow faster. For Liverpool City Region companies in health/life sciences, deep tech, or clean tech.

3Future Medicines Accelerator
CategorySector-specific accelerator programme
Description

Six-month Innovate UK Biomedical Catalyst-funded accelerator programme for SMEs in advanced therapeutics and radiopharmaceuticals, providing tailored guidance, funded technical support, and market potential assessment to prepare for securing funding.

4Pre-seed Investment Fund
CategoryPre-seed investment fund
Description

Pre-seed investment capital for startups in health and life sciences, deep tech, or clean tech in Liverpool City Region, providing funding alongside business support and mentorship.

5Clean Tech for Health Fund
CategoryThematic pre-seed investment fund
Description

Pre-seed investment fund offering up to £100,000 for startups developing innovations that deliver both environmental sustainability and health benefits, funded under the Liverpool City Region Innovation Zone programme.

6R&D Partner Grant Funding
CategoryR&D grant funding
Description

R&D grant funding supporting businesses across net zero, advanced manufacturing, life sciences, and digital technologies to foster new expert partnerships and access funding. Matches investment pound-for-pound up to 50% of eligible costs, up to £15,000.

7Consortia Building
CategoryConsortium building / partnership facilitation
Description

Service for developing large-scale collaborations between established businesses and knowledge base institutions to exploit Liverpool City Region's unique capabilities and assets.

8Entrepreneur Club
CategoryAlumni support programme
Description

Alumni initiative providing ongoing support to founders beyond LYVA Labs' existing programmes through small, expert-led sessions focused on scaling innovative businesses, funding, investor access and sector-specific expertise.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Provides access to technical infrastructure and R&D capabilities for portfolio companies, particularly in the formulation, biotech, and medtech sectors.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic partner providing research expertise, talent pipeline, and technology transfer opportunities for startups in the LYVA Labs portfolio.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

National Science and Innovation Campus providing access to advanced facilities, expertise, and cluster benefits for high-tech startups in the LYVA Labs ecosystem.

4Science and Technology Facilities Council (STFC)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Government body providing access to scientific facilities, technical expertise, and innovation support for portfolio companies requiring specialized R&D infrastructure.

5Infection Innovation Consortium (iiCON)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Infection-focused innovation consortium providing specialized sector expertise and network access for health and life sciences portfolio companies.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Northern England biotech and biomedical network providing sector-specific support and peer connections for life sciences startups.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Banking sector innovation program providing co-working space access and startup ecosystem connections for portfolio companies.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

UK Catapult providing R&D infrastructure and commercialisation support for advanced manufacturing, life sciences, and energy sectors. Named LYVA Labs partner; broader scope and national footprint but overlapping mission of supporting innovative SMEs.

TypeRegional player
Description

Scotland's national economic development agency running innovation, investment, and business support programmes including equity investment funds for early-stage Scottish companies. Comparable public-sector regional innovation investment vehicle, but Scotland-focused rather than North West England.

TypeBroad incumbent
Description

UK's national innovation agency providing grant funding and programmes to UK businesses. A major upstream partner/fund provider to LYVA Labs rather than a competitor; comparable as a UK innovation funding ecosystem actor.

TypeDirect peer
Description

Cambridge University-focused deep tech and life sciences investor. Similar thesis of commercialising research from a specific regional university ecosystem; larger and more established than LYVA Labs but a useful strategic peer.

TypeDirect peer
Description

Northern England membership organisation for biomedical and life sciences companies providing networking, specialist support, and acceleration. Named LYVA Labs partner; comparable Northern England life sciences cluster support organisation.

TypeDirect peer
Description

UK early-stage investor focused on life sciences, technology, and sustainable technology. Named LYVA Labs co-investment partner; comparable pre-seed/seed life sciences investment focus with EIS fund structures for high-growth UK SMEs.

TypeDirect peer
Description

Manchester-based investment firm backing university spinouts in the North of England across deep tech, life sciences, and clean tech. Directly comparable: co-invested with LYVA Labs in Plasma Fresh, similar regional UK university spinout thesis, and overlapping fund partners (e.g., Deepbridge Capital).

TypeDirect peer
Description

University of Oxford-affiliated investor in deep tech and life sciences spinouts. Comparable in mission (commercialising university research) but operates at much larger scale; useful benchmark for institutional-grade UK university spinout investment.

TypeDirect peer
Description

UK-based life sciences incubator and investor that runs accelerator programmes, provides lab infrastructure, and invests in early-stage biotech/health startups. Closely comparable in early-stage life sciences incubation model and accelerator programmes.

TypeDirect peer
Description

UK innovation district operator and investor providing lab infrastructure, business support, and growth capital to science and technology businesses. Comparable regional innovation platform model, though operating at significantly larger scale across multiple UK cities.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment15 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

LYVA Labs

Startup Investment & Innovation Supportlyvalabs.com

LYVA Labs firmographics

Firmographics
Name
LYVA Labs
Legal name
LCR Ventures Ltd
Website
https://lyvalabs.com
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

LYVA Labs industry classification

Industry
Product category
Startup Investment & Innovation Support
NAICS
Grantmaking Foundations (813211), Voluntary Health Organizations (813212)
SIC
Investment Advice (6282)
akta.pro industry
PRIMARYBPAGAKAI
Research & Science Grantmaking Foundations
Business & Public Services/Nonprofit, NGO & Social Services/Philanthropy, Foundations & Grantmaking
SECONDARYBPAGAKAL
Health & Medical Research Grantmaking Foundations
Business & Public Services/Nonprofit, NGO & Social Services/Philanthropy, Foundations & Grantmaking
SECONDARYEDAEALAO
Research Administration & Grants Management Support (Pre/Post-Award, Compliance)
Education/Education Facilities & Support Services/Outsourced Operations & Managed Services for Education (BPO/Contracted Support)
SECONDARYFSANAJAI
Healthcare Access & Life Sciences Impact Funds
Financial & Insurance/Private Equity & Venture Capital/Impact / ESG & Sustainable Investment Funds
SECONDARYHLAJALAM
Workforce Development & Training Grants (Public Health)
Healthcare & Life Sciences/Public Health, Government & Regulators/Public Health Funding, Grants & Program Administration

Keywords

  • Pre-seed investment
  • Startup incubator programs
  • Innovation accelerator services
  • R&D grant funding
  • Venture capital support

Where LYVA Labs is headquartered

Location

Headquarters

HQ city
Liverpool
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

LYVA Labs business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Grant-Funded Operations: LYVA Labs operates as a publicly-funded innovation catalyst supported by the Liverpool City Region Combined Authority and UKRI/Innovate UK. The organization deploys investment capital and grant facilitation services at no cost to early-stage companies, generating social and economic returns for the region rather than commercial revenue.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractFree support programs for qualifying early-stage companies

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

LYVA Labs product offering

Product offering

Core offering

LYVA Labs is Liverpool City Region's innovation investment company, providing pre-seed investment capital alongside structured Incubator (six-month) and Accelerate (nine-month) programmes, the Future Medicines Accelerator for advanced therapeutics and radiopharmaceuticals SMEs, R&D Partner Grant Funding matching up to £15,000 pound-for-pound, Consortia Building services for large-scale collaborations, and the Clean Tech for Health Fund offering up to £100,000. Its core focus sectors are health and life sciences, deep tech, and clean tech, and all services are delivered free of charge to qualifying early-stage startups and SMEs through public funding.

Product overview

LYVA Labs is Liverpool City Region's innovation investment company that operates as a platform of interconnected support services rather than a single software product. The core offering comprises an Incubator Programme (6-month early-stage support with £25k investment), Accelerate Programme (9-month scale-up support), and Future Medicines Accelerator (Innovate UK-funded sector-specific programme). These are complemented by the Investment Fund (pre-seed capital for health, deep tech, and clean tech startups), R&D Partner Grant Funding (pound-for-pound matching grants up to £15k), Consortia Building services, and the Clean Tech for Health Fund (up to £100k pre-seed for sustainability-health innovations). The Entrepreneur Club provides ongoing alumni support. All programmes are delivered in partnership with regional institutions including Liverpool City Region Combined Authority, UKRI, Innovate UK, universities, and industry partners.

Differentiator

Problem solved

Functional benefit

Brands

  • Incubator Programme: Early-stage support for founders developing innovative ideas into viable, investable businesses
  • Accelerate Programme
  • Future Medicines
  • R&D Funding
  • Consortia
  • Clean Tech for Health Fund

Products and services

  • Incubator Programme Six-month early-stage startup support programme offering £25,000 investment or consultancy budget, personalised account management, expert-led workshops, bespoke mentoring, grant application assistance, and concluding Demo Day investor pitches. For early-stage founders developing innovative ideas into viable, investable businesses in health/life sciences, deep tech, or clean tech.
  • Accelerate Programme Nine-month intensive programme providing tailored expert support, guidance, and strategic insight for startups and SMEs ready to scale, secure investment and grow faster. For Liverpool City Region companies in health/life sciences, deep tech, or clean tech.
  • Future Medicines Accelerator Six-month Innovate UK Biomedical Catalyst-funded accelerator programme for SMEs in advanced therapeutics and radiopharmaceuticals, providing tailored guidance, funded technical support, and market potential assessment to prepare for securing funding.
  • Pre-seed Investment Fund Pre-seed investment capital for startups in health and life sciences, deep tech, or clean tech in Liverpool City Region, providing funding alongside business support and mentorship.
  • Clean Tech for Health Fund Pre-seed investment fund offering up to £100,000 for startups developing innovations that deliver both environmental sustainability and health benefits, funded under the Liverpool City Region Innovation Zone programme.
  • R&D Partner Grant Funding R&D grant funding supporting businesses across net zero, advanced manufacturing, life sciences, and digital technologies to foster new expert partnerships and access funding. Matches investment pound-for-pound up to 50% of eligible costs, up to £15,000.
  • Consortia Building Service for developing large-scale collaborations between established businesses and knowledge base institutions to exploit Liverpool City Region's unique capabilities and assets.
  • Entrepreneur Club Alumni initiative providing ongoing support to founders beyond LYVA Labs' existing programmes through small, expert-led sessions focused on scaling innovative businesses, funding, investor access and sector-specific expertise.

Quantifiable outcome

  • 35 early-stage companies invested in
  • +3 more outcomes

Companies that use LYVA Labs

Customer profile

Named customers3 records

Segments2 records

Ideal customer profiles2 records

LYVA Labs technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability7 records

LYVA Labs partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core and minor.

  • Centre for Process Innovation (CPI)coreStrategic or Co-development PartnerProvides access to technical infrastructure and R&D capabilities for portfolio companies, particularly in the formulation, biotech, and medtech sectors.
  • University of LiverpoolcoreStrategic or Co-development PartnerAcademic partner providing research expertise, talent pipeline, and technology transfer opportunities for startups in the LYVA Labs portfolio.
  • Sci-Tech DaresburycoreStrategic or Co-development PartnerNational Science and Innovation Campus providing access to advanced facilities, expertise, and cluster benefits for high-tech startups in the LYVA Labs ecosystem.
  • Science and Technology Facilities Council (STFC)coreStrategic or Co-development PartnerGovernment body providing access to scientific facilities, technical expertise, and innovation support for portfolio companies requiring specialized R&D infrastructure.
  • Infection Innovation Consortium (iiCON)minorStrategic or Co-development PartnerInfection-focused innovation consortium providing specialized sector expertise and network access for health and life sciences portfolio companies.
  • BionowminorStrategic or Co-development PartnerNorthern England biotech and biomedical network providing sector-specific support and peer connections for life sciences startups.
  • Barclays Eagle LabsminorStrategic or Co-development PartnerBanking sector innovation program providing co-working space access and startup ecosystem connections for portfolio companies.

Scale indicators6 records

Recent moves7 records

Expansion highlights5 records

LYVA Labs competitors and assessment

Company assessment

Broad incumbents

  • Centre for Process Innovation (CPI): UK Catapult providing R&D infrastructure and commercialisation support for advanced manufacturing, life sciences, and energy sectors. Named LYVA Labs partner; broader scope and national footprint but overlapping mission of supporting innovative SMEs.
  • Innovate UK: UK's national innovation agency providing grant funding and programmes to UK businesses. A major upstream partner/fund provider to LYVA Labs rather than a competitor; comparable as a UK innovation funding ecosystem actor.

Regional players

  • Scottish Enterprise: Scotland's national economic development agency running innovation, investment, and business support programmes including equity investment funds for early-stage Scottish companies. Comparable public-sector regional innovation investment vehicle, but Scotland-focused rather than North West England.

Direct peers

  • Cambridge Innovation Capital: Cambridge University-focused deep tech and life sciences investor. Similar thesis of commercialising research from a specific regional university ecosystem; larger and more established than LYVA Labs but a useful strategic peer.
  • Bionow: Northern England membership organisation for biomedical and life sciences companies providing networking, specialist support, and acceleration. Named LYVA Labs partner; comparable Northern England life sciences cluster support organisation.
  • Deepbridge Capital: UK early-stage investor focused on life sciences, technology, and sustainable technology. Named LYVA Labs co-investment partner; comparable pre-seed/seed life sciences investment focus with EIS fund structures for high-growth UK SMEs.
  • Northern Gritstone: Manchester-based investment firm backing university spinouts in the North of England across deep tech, life sciences, and clean tech. Directly comparable: co-invested with LYVA Labs in Plasma Fresh, similar regional UK university spinout thesis, and overlapping fund partners (e.g., Deepbridge Capital).
  • Oxford Sciences Innovation: University of Oxford-affiliated investor in deep tech and life sciences spinouts. Comparable in mission (commercialising university research) but operates at much larger scale; useful benchmark for institutional-grade UK university spinout investment.
  • BioCity (now part of Pioneer Group): UK-based life sciences incubator and investor that runs accelerator programmes, provides lab infrastructure, and invests in early-stage biotech/health startups. Closely comparable in early-stage life sciences incubation model and accelerator programmes.
  • Bruntwood SciTech: UK innovation district operator and investor providing lab infrastructure, business support, and growth capital to science and technology businesses. Comparable regional innovation platform model, though operating at significantly larger scale across multiple UK cities.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

LYVA Labs social profiles

Digital presence

LYVA Labs financial estimates

Financial estimate

Revenue estimate

Valuation estimate

LYVA Labs leadership team

Management profile

Number of profiles

Profiles12 records

LYVA Labs funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

LYVA Labs M&A and investment

M&A and investment

M&A

Investments15 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LYVA Labs

What does LYVA Labs do?

LYVA Labs is Liverpool City Region's innovation investment company, providing pre-seed investment capital alongside structured Incubator (six-month) and Accelerate (nine-month) programmes, the Future Medicines Accelerator for advanced therapeutics and radiopharmaceuticals SMEs, R&D Partner Grant Funding matching up to £15,000 pound-for-pound, Consortia Building services for large-scale collaborations, and the Clean Tech for Health Fund offering up to £100,000. Its core focus sectors are health and life sciences, deep tech, and clean tech, and all services are delivered free of charge to qualifying early-stage startups and SMEs through public funding.

Is LYVA Labs a public or private company?

LYVA Labs is a private company. It is classified as state government owned and is currently operating.

When was LYVA Labs founded?

LYVA Labs was founded in 2021. It employs 11 to 50 people.

Where is LYVA Labs based?

LYVA Labs is headquartered in Liverpool, United Kingdom, in the Europe region.

How does LYVA Labs make money?

One revenue line is on record: grant-Funded Operations.

Who are LYVA Labs's main competitors?

Broad incumbents on record are Centre for Process Innovation (CPI) and Innovate UK. Scottish Enterprise is listed as a regional player. Direct peers are Cambridge Innovation Capital, Bionow, Deepbridge Capital, Northern Gritstone, Oxford Sciences Innovation, BioCity (now part of Pioneer Group) and Bruntwood SciTech.

Does LYVA Labs have an API?

No public API is recorded for LYVA Labs.

What industry is LYVA Labs in?

LYVA Labs's product category is Startup Investment & Innovation Support. Its primary akta.pro industry code is BPAGAKAI, Research & Science Grantmaking Foundations, with a secondary code of BPAGAKAL, Health & Medical Research Grantmaking Foundations. Its NAICS code is 813211 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Pulse 2.0Medcotec Raises More Than £2.4 Million To Commercialize Helyx Powder Transfer ValveMedcotec raised over £2.4 million to commercialize Helyx, a single-use powder transfer valve. The funding, from NPIF II and LYVA Labs, will support trials, market launch, and hiring. The valve aims to reduce contamination and blockages in pharmaceutical manufacturing.InsidermediaLife sciences start-up raises £2.4m - “our valve could be a gamechanger for the industry”Medcotec, a Daresbury-based start-up, raised over £2.4m from NPIF II, LYVA Labs, and private investors to commercialize its powder transfer valve. The funding will support further trials and team expansion, with the company expecting to create four new jobs in 12 months.BdailyMedcotec secures funding to scale safety valveMedcotec, a North West life sciences start-up, secured over £2.4 million in investment from NPIF II, LYVA Labs, and private investors to bring its Helyx powder transfer valve to market. The funding supports product trials and plans to double its four-strong workforce. The valve aims to reduce contamination and production failures, which cost the global pharmaceutical industry £9 billion annually.InsidermediaLYVA Labs Incubator launches search for 2027 cohortLYVA Labs Incubator opened applications for its 2027 cohort, a six-month programme for early-stage start-ups in health, clean tech, and deep tech. Since 2024, it has supported 24 start-ups with up to £25,000 investment, and companies have received £895,000 in investment, £3.1m in co-investment, and £3.3m in grant funding.LyvalabsLYVA Labs backs Spotlight Pathology’s AI blood cancer diagnosticsLYVA Labs, a Liverpool City Region Combined Authority funded investor, has invested £250,000 into Spotlight Pathology as part of a £1.4 million seed funding round that also includes Liverpool Seed Fund, Deepbridge Capital, River Capital, UKI2S, and EHE Startup Factory. The funding will support the commercialisation of Spotlight Pathology's AI-powered diagnostic tools for blood cancers including lymphoma and leukaemia, and is expected to create six new jobs in the Liverpool City Region. Spotlight Pathology, which was originally spun out of the University of Manchester and is now headquartered at Sci-Tech Daresbury, was founded by Dr Martin Fergie and Professor Richard Byers alongside CEO Dr Sam Perona.LyvalabsLYVA Labs invests in OCUWELL to transform global eye-care technologyOCUWELL Ltd has secured new investment from LYVA Labs, the University of Liverpool, Deepbridge Capital, and Northern Gritstone to support the commercialization of its corneal topography system. The funding will enable OCUWELL to bring its OCUTOP® handheld device and OCUGRAPH® software suite to market, expanding its commercial team and advancing its position in digital eye health.InsidermediaLancaster University spin-out secures major funding boost for diagnostics technologyLancaster University spin-out CCI Photonics secured over £400,000 in funding for its AI-based diagnostics that detect infectious diseases and antibiotic susceptibilities in under 15 minutes. The investment includes £200,000 from NPIF II, £150,000 from iiCON, and £100,000 from Lyva Labs, supporting collaboration with the Liverpool School of Tropical Medicine.BusinessCloudLancaster University spinout aims to identify infection in 15 minutesCCI Photonics, a Lancaster University spinout, secured six-figure funding to develop a diagnostic device that detects bacterial infections and antibiotic susceptibilities in under 15 minutes. The funding includes £200,000 from NPIF II, £150,000 from iiCON, and £100,000 from Lyva Labs, with validation planned with the Liverpool School of Tropical Medicine.BusinessCloudInvestment to power University of Liverpool spinout AtomikUniversity of Liverpool spinout Atomik AM received £125k from LYVA Labs to accelerate product commercialisation. The funding will support new IP, a patent, eight jobs, and a COO role. The investment follows a successful exit from Meta Additive Ltd.LiverpoolEngineering spin-out secures £125k investment from LYVA LabsAtomik AM, a University of Liverpool spin-out, secured £125k from LYVA Labs to accelerate commercialization of binder jetting techniques. The funding will support new IP, a patent, eight jobs, and a chief operating officer role. The company aims to convert pipeline opportunities into commercial contracts.